Soons, E.
Rath, T.
Hazewinkel, Y.
van Dop, W. A.
Esposito, D.
Testoni, P. A.
Siersema, P. D.
Article History
Accepted: 18 September 2022
First Online: 27 September 2022
Declarations
:
: The study protocol was approved by the local institutional review board in each participating center, and the study was performed in accordance with the Helsinki Declaration. The study was monitored in accordance with good clinical practice (GCP) principles.
: All participants gave written informed consent before participating in the study.
: Author Peter Siersema receives unrestricted grants from Pentax (Japan), Norgine (UK), Motus GI (USA), MicroTech (China), and The eNose Company (Netherlands) and is in the advisory board of Motus GI (USA) and Boston Scientific (USA). Authors Elsa Soons, Timo Rath, Yark Hazewinkel, Willemijn van Dop, Dario Esposito, and Pier Alberto Testoni have no conflicts of interest or financial ties to disclose.